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Abstract
The transporter associated with antigen processing (TAP) translocates the cytosol-derived proteolytic peptides to the
endoplasmic reticulum lumen where they complex with nascent human leukocyte antigen (HLA) class I molecules. Non-
functional TAP complexes and viral or tumoral blocking of these transporters leads to reduced HLA class I surface expression
and a drastic change in the available peptide repertoire. Using mass spectrometry to analyze complex human leukocyte
antigen HLA-bound peptide pools isolated from large numbers of TAP-deficient cells, we identified 334 TAP-independent
ligands naturally presented by four different HLA-A, -B, and -C class I molecules with very different TAP dependency from
the same cell line. The repertoire of TAP-independent peptides examined favored increased peptide lengths and a lack of
strict binding motifs for all four HLA class I molecules studied. The TAP-independent peptidome arose from 182 parental
proteins, the majority of which yielded one HLA ligand. In contrast, TAP-independent antigen processing of very few cellular
proteins generated multiple HLA ligands. Comparison between TAP-independent peptidome and proteome of several
subcellular locations suggests that the secretory vesicle-like organelles could be a relevant source of parental proteins for
TAP-independent HLA ligands. Finally, a predominant endoproteolytic peptidase specificity for Arg/Lys or Leu/Phe residues
in the P1 position of the scissile bond was found for the TAP-independent ligands. These data draw a new and intricate
picture of TAP-independent pathways.
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Introduction
Proteolysis, by the proteasome and other cytosolic proteases, of
both newly synthesized proteins and the mature cell proteome
continuously generates short peptides that are transported into the
endoplasmic reticulum (ER) by the transporter associated with
antigen processing (TAP) [1]. These peptides are assembled with
a nascent HLA class I heavy chain and b2-microglobulin to
generate stable HLA/peptide complexes that are exported to the
cell membrane and subjected to cytotoxic CD8+ T lymphocyte
recognition (reviewed in [2]).
Non-functional TAP complexes, which can be produced by
mutations in the TAP gene, have been described in both humans
[3] and mice [4]. Patients with an HLA class I deficiency have
a reduced functional CD8+ population but may appear asymp-
tomatic for long periods of time with only a limited susceptibility to
chronic respiratory bacterial infections. Thus, their immune
systems must be reasonably efficient, and in addition to different
unaltered layered defenses, it remains possible that the reduced
cytolytic CD8+ ab T subpopulation that is specific for TAP-
independent antigens may contribute to immune defenses that
protect against severe infections in these individuals.
Although TAP-independent viral epitopes are known (reviewed
in [5–7]), few studies have analyzed the cellular TAP-independent
HLA class I peptide repertoire. TAP-deficient cells have been
described as having very limited antigen processing capacity [8],
with predominant proteolytic ER signal peptidase (SPase) activity
[9]. Therefore, is the TAP-independent HLA peptidome so
limited in TAP-deficient cells, as suggested by these studies? The
identification of self-derived ligands presented in the same cells by
several common HLA antigens with very different TAP de-
pendency is of major interest. Therefore, using a high-throughput
immunopeptidomics analysis, we analyzed the TAP-independent
HLA peptidome isolated from large numbers of TAP-deficient
cells and bound to different HLA alleles. In this study, we
identified more than three hundred TAP-independent ligands
bound to different HLA-A, -B, and -C class I molecules.
PLOS ONE | www.plosone.org 1 March 2013 | Volume 8 | Issue 3 | e59118
Materials and Methods
Cell Lines
T2 is a human T cell leukemia/B cell line hybridoma cell line
that has a large homozygous deletion within the MHC, including
both TAP genes and all of the functional class II genes [10–12]. In
addition, this cell line expresses low levels of HLA class I molecules
on the cell surface [13]. T2 cells transfected with B*2705 have
been previously described [14]. Transfected RMA-S tumour of T
cells (deficient in TAP that expresses low levels of cell surface
MHC class I) expressing HLA-B*2705 have also been previously
described [15]. All cell lines were cultured in RPMI 1640
supplemented with 10% fetal bovine serum (FBS) and 5 mM b-
mercaptoethanol.
Synthetic Peptides
Peptides were synthesized in a peptide synthesizer (model 433A;
Applied Biosystems, Foster City, CA) and purified by reversed-
phase HPLC. The correct molecular mass of each peptide was
established with a Reflex IV MALDI-TOF instrument (Brucker-
Franzen Analytik, Bremen, Germany), and their correct compo-
sition was determined with a Deca XP LCQ mass spectrometer
(Thermo Fisher, San Jose, CA).
Isolation of HLA-bound Peptides
HLA-bound peptides were isolated from 4 x 1010 healthy T2-
B27 transfected cells or vaccinia (VACV)-WR-infected T2-B27
transfected cells. Cells were lysed at 4uC in 1% CHAPS (Sigma),
20 mM Tris/HCl buffer, and 150 mM NaCl, pH 7.5, in the
presence of a protease inhibitor cocktail [16,17]. First of all, the
soluble fraction of cell extracts was treated with immunoaffinity
columns without antibody to discard unspecific binding of
peptides. Next, HLA-peptide complexes were isolated via affinity
chromatography of the soluble fraction of cell extracts with the
following mAbs, used sequentially: PA2.1 (anti-HLA-A2) [18],
ME1 (anti-HLA-B27) [19], and W6/32 (specific for a mono-
morphic HLA class I determinant) [20] (Figure S1). HLA-bound
peptides were eluted at room temperature with 0.1% aqueous
trifluoroacetic acid (TFA), separated from the large subunits and
concentrated with a Centricon 3 ultrafiltration device (Amicon,
Beverly, MA) exactly as previously described [16,17].
Electrospray-Orbitrap Mass Spectrometry Analysis
Peptide mixtures recovered after the ultra-filtration step were
concentrated with Micro-Tip reverse-phase columns (C18, 200 ml,
Harvard Apparatus, Holliston, MA) [16]. Each C18 tip was
equilibrated with 80% acetonitrile in 0.1% TFA, washed with
0.1% TFA, and then loaded with the peptide mixture. The tip was
then washed with an additional volume of 0.1% TFA and the
peptides were eluted in 300 ml with 80% acetonitrile in 0.1% TFA.
Peptide samples were then concentrated to approximately 18 ml
using vacuum centrifugation [16,17].
HLA class I peptides that had been immunoprecipitated with
each HLA-specific mAb were analyzed by mLC-MS/MS using an
Orbitrap XL mass spectrometer (Thermo Fisher) fitted with
a capillary HPLC (Eksigent, Dublin, CA) [16,17]. The peptides
were resolved on homemade Reprosil C18 capillary columns (75
micron ID) [21] with a 7%–40% acetonitrile gradient for 2 h in
the presence of 0.1% formic acid. The seven most intense masses
that exhibited single-, double-, and triple-charge states were
selected for fragmentation from each full mass spectrum by
collision-induced dissociation.
Database Searches
Raw mass spectrometry data were analyzed using various
software tools: Proteome Discoverer 1.0 SP1 (Thermo-Fisher)
combining the results of Sequest 3.31 and Bioworks Browser 3.3.1
SP1 (Thermo-Fisher) [22], using the human part of the NCBI
database (Feb 2012) including 729,880 proteins. The search was
not limited by enzymatic specificity, the peptide tolerance was set
to 0.01 Da, and the fragment ion tolerance was set to 0.5 Da
[16,17]. Oxidized methionine was searched as a variable modi-
fication. Other search criteria were set such that the search was not
limited by any methodological bias (selection of individual protein,
use of HLA consensus scoring algorithms, etc.). To exclude
peptides that could contaminate the peptide pool, a search using
the bovine part of the NCBI database (Feb 2012) including 29,925
proteins was performed. No bovine serum peptides were identified
bound to HLA class I molecules.
Identified peptides were selected if the following criteria were
met: mass accuracy #0.005 Da or ,5 ppm; Sequest Xcorr .1.5
for singly, .2.5 for doubly, and .3.5 for triply charged peptides;
DCn .0.1; Proteome Discovered P score .20; and P(pep)
,161022 with Bioworks Browser [16,17]. When the MS/MS
spectra fitted more than one peptide, only the highest scoring
peptide was selected. The false-positive rate for peptide identifi-
cation yielded a 2% based on a search of a reversed database,
wherein the amino acid sequences of all proteins are reversed. In
addition, two synthetic peptides were made, and their MS/MS
spectra were used to confirm the assigned sequences (Figures S2
and S3).
MHC/Peptide Stability Assays
The following synthetic peptides were used as controls in
complex stability assays: Flu NP (SRYWAIRTR, HLA-B27-
restricted) [23], RSV M76–84 (SRSALLAQM, HLA-B27-restrict-
ed) [16], and C4CON (QYDDAVYLK, HLA-Cw4-restricted)
[24]. RMA-S B*2705 transfectant cells were incubated at 26uC for
16 h in RPMI 1640 medium supplemented with 10% heat-
inactivated FBS. This allows the expression of empty MHC class I
molecules (without antigenic peptide) at the cellular membrane
that are stable at 26uC but not at 37uC. The cells were washed and
incubated for 2 h at 26uC with various concentrations of peptide
in the same medium without FBS. The cells were maintained at
37uC for an additional 4 h and then collected for flow cytometry.
This method allows empty MHC class I molecules to become
internalized and can thus discriminate between bound and
unbound peptides. MHC expression was measured using 100 ml
of hybridoma culture supernatant containing ME1 (anti-HLA-
B27) mAb as previously described [25]. Samples were acquired on
a FACSCanto flow cytometer (BD Biosciences, San Jose, CA,
USA) and analyzed using CellQuest Pro 2.0 software (BD
Bioscience). Cells incubated without peptide had peak fluorescence
intensities close to background staining with secondary Ab alone.
The fluorescence index was calculated at each time point as the
ratio of the mean channel fluorescence of the sample to that of the
control incubated without peptide. The data are mean values of
the three experiments.
Results
Physiological Processing Generates Multiple Cellular
Ligands Bound to HLA Alleles with Distinct TAP
Dependency in the Same Human TAP-deficient Cell Line
To date, approximately 70 human TAP-independent ligands
from classical HLA class I molecules are known [7,9], and are
mostly restricted to HLA-A2 and derived by cleavage of signal
Natural HLA Peptidome in TAP-Deficient Cells
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sequences generated by the SPase complex. Thus, the comparison
of TAP-independent peptide pools derived from HLA-A2, HLA-
B27, an allele high TAP-dependent [26], and other HLA class
molecules, such as HLA-B51 or -Cw1, with no data about their
TAP dependency, could be relevant in the study of alternative
antigen processing pathways.
In a previous study, HLA-A2, -B27, -B51, and -Cw1-bound
peptide pools were isolated from large amounts of either healthy or
the vaccinia (VACV)-infected human TAP-deficient cell line
(Figure S1) and eleven VACV viral ligands were identified [17].
Moreover, the use of several software tools in these same samples
over a human proteome database resolved 111, 77, and 192
fragmentation spectra as peptidic sequences of different human
cellular proteins bound to HLA-A2 (Table S1), -B27 (Table S2),
and -B51 or -Cw1 (Table S3), respectively. Two different peptide
sequences were selected as additional controls for assignment.
Both the experimentally detected and the corresponding synthetic
peptide MS/MS spectra were identical (Figures S2 and S3). To
confirm that HLA-B27 is the MHC class I molecule that presents
these ligands, MHC/peptide complex stability assays were
performed using TAP-deficient RMA-S cells transfected with the
HLA-B27 molecule (Fig. S4).
Collectively, these results indicate that a similar broad range of
TAP-independent ligands was endogenously processed and
presented by different HLA class I molecules in the same infected
cells, despite their differences in TAP dependency [26].
Structural Features of TAP-independent HLA Ligands
HLA-A2, -B51, and -Cw1 class I molecules usually bind
peptides approximately 9–11 residues long (SYFPEITHI database:
http://www.syfpeithi.de [27]), whereas HLA-B27 could accom-
modate peptides up to 13–14 residues in a bulged conformation
(SYFPEITHI database, [28]). The analysis of size indicated that
approximately 60% of the TAP-independent HLA-A2, -B51, or -
Cw1 ligands and 40% of the -B27 ligands are longer than those
identified in TAP-sufficient cells (Fig. S5). We next studied the
anchor motif requirements of these ligands. The HLA-A2, -B51,
and -Cw1 alleles present peptides with partially similar anchor
motifs (SYFPEITHI database). The classical position 2 anchor
motifs are as follows: for HLA-A2 binding, Leu or Met; for HLA-
B51, Pro and Ala; and for HLA-Cw1, Ala and Leu. Aliphatic CV
residues (SYFPEITHI database) are common between these three
HLA alleles. For HLA-B27, the anchor motif consists of Arg or
Gln at P2 and basic or aliphatic CV residues (SYFPEITHI
database, [28]). However, the respective anchor motifs were
absent in 60–70% of the TAP-independent HLA ligands (Table 1).
Likewise, the amino acid preference at the CV position was
studied and revealed major discrepancies among the HLA-A2, -
B51 and -Cw1 ligands of TAP-sufficient versus TAP-deficient cells,
although no differences in HLA-B27 ligands were found (Table 1).
These data suggest that the relative contribution of the CV pocket
to the stabilization of unusual peptides differs among these HLA
class I alleles.
It is well documented that HLA-A2 binds signal sequence-
derived peptides generated by the cleavage of signal sequences
from the parental polypeptide by the signal peptidase (SPase)
complex [9]. We found that 11% of peptides that bound to the
HLA-A2 molecule were derived from the signal sequence of
various proteins (Table 2). In addition, 3% of HLA-B27 and -B51
or -Cw1 ligands are located in the region generated by SPase
activity (Table 2). Most importantly, a significant fraction of bound
ligands identified from HLA-A2 (17%)-, -B27 (23%)- and -B51 or -
Cw1 (24%)-associated repertoires are located at the C-terminal
position of their respective proteins. Thus, only one endoproteo-
lytic cleavage was needed to release these particular ligands. In
contrast, the remainder of peptides required two endoproteolytic
cleavages for their generation. Unexpectedly, a similar fraction of
the double cleaved HLA ligands were nested set peptides with an
identical core but with N- and/or C-extended residues from the
same protein (Table 2 and Tables S1, S2, and S3). Representative
nested set peptides are depicted in Figure S6.
TAP-independent Processing Generates Multiple HLA
Ligands from the same Cellular Proteins
In addition to N- and C-extended peptides (Tables S1, S2 and
S3, and Figure S6), some proteins contributing different clustered
HLA ligands were identified by mass spectrometry (Tables S1, S2,
S3, and S4). Figure 1 depicts a representative example. In the first
80 residues of myosin heavy polypeptide 9 protein, different
adjacent or superimposed HLA ligands were processed. In
addition, other N- and C-terminal extended peptides that were
identified as binding to different HLA class I molecules were
identified from the same protein (Figure 1, panel B). Thus, these
data indicate that extensive processing of N- and C-terminal
regions of some proteins occurs via TAP-independent antigen
processing pathways. These recurrent endoproteolytic activities
were not restricted based on their location within the polypeptide
because several HLA ligands were identified that constitute
internal regions of some proteins (Figure S7 and Table S4).
In total, one-fifth of the identified proteins were processed, and
their ligands were later presented by two different HLA class I
molecules. Approximately 6% of the identified proteins generated
multiple TAP-independent ligands associated with HLA-A2, -B27,
and -B51 or –Cw1 class I molecules (Table 3 and Tables S4 and
S5).
Collectively, these data indicate that some proteins could be
widely processed by proteases via TAP-independent pathways,
yielding multiple peptides that could be presented by different
HLA class I molecules. Thus, these data suggest that greater
proteolytic processing occurs than previously supposed in TAP-
independent antigen processing pathways.
Cellular Location of Parental Proteins for TAP-
independent HLA Ligands
The 334 TAP-independent ligands identified by mass spec-
trometry arose from 182 parental proteins. Table 4 shows the
predicted organelle location of these proteins based on the Gene
Ontology database (http://www.geneontology.org) [29]. One-
third of the parental proteins were from the ER (8%), Golgi
(4%), plasma membrane (14%), and secretory granules (6%),
which likely represents their direct processing from transported
proteins by resident proteases in the HLA-loading compartments.
Strikingly, approximately two-thirds of the parental proteins were
from non-secretory subcellular compartments, such as the nucleus
(32%), cytoplasm (22%), cytoskeleton (9%), and mitochondria
(5%). As such, their respective proteins and/or processed ligands
must be transported into the ER lumen by a yet unknown pathway
to yield TAP-independent antigen presentation.
The Secretory Vesicle-like Organelle could be an
Important Source of Parental Proteins for HLA TAP-
independent Ligands
Various TAP-independent ligands from several lysosomal
proteins (e.g., lysosomal multispanning membrane protein 5,
Figure S6) were identified. Thus, an attractive hypothesis arose
that pointed to protein digestion within this degradative organelle
as the source of most of the parental proteins yielding the TAP-
Natural HLA Peptidome in TAP-Deficient Cells
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independent ligands identified by mass spectrometry. Thus, the
distribution of both the source proteins of the TAP-independent
peptidome and those of the lysosomes previously published [30,31]
was compared. Table 4 shows a very different pattern of organelle
location of constitutive proteins between this subcellular organelle
and the TAP-independent peptidome. Thus, the lysosomes are not
likely to be the primary source of peptides in the TAP-independent
peptidome. As some lysosomal proteins are expressed in other
secretory organelles, and because diverse vesicular organelles
harbor different organelle-specific constitutive proteins, the
composition of several organelles was analyzed. Only secretory
vesicles from human neutrophils [32], similar to those identified in
several immune cells including T and B cells) [33,34], have shown
a similar predominance of cytoplasm, nucleus and plasma
membrane proteins in the ratios observed for the TAP-in-
dependent peptidome (Table 4). Further, 51% of the parental
proteins identified as part of the TAP-independent peptidome
(Table S6) were previously found in the proteome of this secretory
vesicle [32]. Thus, secretory-like vesicles could be a relevant source
of the parental proteins observed during TAP-independent
antigen processing.
Cleavage Specificity of Peptidases Over TAP-independent
Ligands
Next, to study the specificity of peptidases involved in the
generation of ligands in TAP-defective cells, an analysis was
carried out that used mass spectrometry to detect residues on both
sides of the hydrolyzed bonds of HLA ligands. When several
nested peptides were found, amino and/or carboxyl peptidase
activities could be assumed. Accordingly, only the higher possible
HLA ligand was examined. Under this hypothesis, 264 TAP-
independent ligands (the 79% of peptidome) were analyzed.
Figure 2 shows the distribution of amino acids found in the
immediate flanking positions of scissile bonds (P1 or P91 residues).
The relative abundance of most amino acids was similar when P91,
but not P1, residues of HLA ligands were analyzed (panel B versus
C). This was also true when the analysis was performed on each
individual HLA class I molecule studied (data not shown).
Additionally, no correlation was found when similar analyses of
P2, P3, P92, and P93 positions were performed (data not shown). In
summary, these results indicate that proteases with specificity to
some residues in P1, but not other positions, make the
endoproteolytic cleavages to generate TAP-independent ligands.
Only four amino acids (Arg, Leu, Lys, and Phe) are increased in
the P1 positions of scissile bonds, which accounted for up to 10%
of the total cleavages detected (Fig. 2, panel B). These four major
P1 residues could be processed by different proteases or may
represent the specificities of one or a few proteases that generate
both P1 cleavage positions. To resolve these questions, an analysis
of the correlation between these four specific amino acid residues
and the opposite P1 N- or C-end residues of HLA ligands was
carried out. When Arg was the P1 C-end of an HLA ligand
identified by mass spectrometry, only two amino acid residues (Arg
and Lys) were predominantly located in the corresponding P1 N-
end position (Fig. 3B, white boxes). This was true also for the
reverse situation; when Arg was the P1 N-end position, the amino
acid residues predominantly located in the P1 C-end position were
also Arg and Lys (Fig. 3B, black boxes). Further, an identical
correspondence in the analysis of Lys residue was found with both
the P1 N- and C-end positions (Fig. 3C). Similar analyses with Phe
P1 cleavages have shown that only Phe and Leu residues were
mainly located in the equivalent P1 N- or C-end positions of scissile
bonds (Fig. 3D). A minor correlation with the Leu cleavage
analysis was found, although Phe and Leu remained as the most
abundantly detected residues (Fig. 3E). As several endoproteolytic
peptidases have specificity for Arg/Lys or Leu/Phe in the P1
position of the scissile bond (MEROPS database: http://merops.
sanger.ac.uk [35]), the enzymatic activity of only two of these types
of peptidases could explain more than half of the identified
cleavages derived from the detected TAP-independent ligands
(Table S7).
Low Hydrophobicity in TAP-independent Virus Ligands
In cells infected with the Epstein-Barr virus (EBV), only peptides
with high hydrophobicity from the BRLF1 and LMP2 proteins
Table 1. Amino acid preference at anchor motif P2 and CV positions in TAP-dependent versus TAP-independent ligands.
Position Residue HLA-A2 Residue HLA-B27 Residue HLA-B51, Cw1
TAP+a TAP2b TAP+c TAP2d TAP+e TAP2f
P2 L/M 73 42 R/Q 100 28 L/A/P 81 39
CV L/V/I/A 92 41 R/F/K/L/Y 91 78 V/I/L 83 31
a424 HLA-A2 ligands from SYFPEITHI database.
b111 HLA-A2 TAP-independent ligands, see Table S1.
c571 HLA-B27 ligands [28].
d77 HLA-B27 TAP-independent ligands, see Table S2.
e68 HLA-B51 and 9 HLA-Cw1 ligands from SYFPEITHI database.
f192 HLA-B51 and -Cw1TAP-independent ligands, see Table S3.
gData are expressed in percentage.
doi:10.1371/journal.pone.0059118.t001
Table 2. Major features of TAP-independent HLA ligands.
Type of peptide HLA-A2 HLA-B27 HLA-B51, -Cw1
Signal sequencea 11b 3 3
C-terminalc 17 23 24
N-extendedd 10 18 11
C-extendede 4 8 4
N- and C-extended 1 0 1
Total of extended 15 26 16
aPeptides located into signal sequence of respective protein.
bData are expressed in percentage of total TAP-independent ligands.
cPeptides located in C-terminal position of respective protein.
dN-extended peptides respect the minimal ligand identified with identical core.
eC-extended peptides respect the minimal ligand identified with identical core.
doi:10.1371/journal.pone.0059118.t002
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were processed by TAP-independent pathways [36,37]. In
contrast, hydrophobicity is not a necessary condition for the
TAP-independent presentation of vaccinia virus ligands [17].
Because the total number of viral ligands in both studies was low
(eight and eleven ligands from EBV or vaccinia virus, respectively),
the study of the hydrophobicity of more abundant cellular TAP-
independent ligands could be important. The grand average of
hydropathicity (GRAVY) (ProtParam tool, ExPASy Proteomics
Server, http://www.expasy.ch) mean of approximately
1,000 HLA-A2, -B27, -B51, and -Cw1 TAP-dependent ligands
previously described (Table 1) was only 0.061.0, and significant
differences between the different HLA alleles studied were not
found (data not shown), indicating that no hydrophobicity of these
HLA ligands exists. A very similar GRAVY measurement
(20.360.8) was found for the 337 TAP-independent ligands
described in this report. These results show that hydrophobicity is
not a necessary condition for the overall TAP-independent
presentation of cellular ligands.
Discussion
Identification of self-derived HLA ligands by mass spectrometry
analysis contributes to a better understanding of the mechanisms
of antigen presentation that are associated with the cellular
immune response. While several hundred peptides bound to
specific MHC class I alleles are identified in any given
immunoproteomics analysis from TAP-sufficient cells, only some
tens have been described for TAP-independent HLA ligands from
the still very limited number of immunoproteomics studies from
TAP-deficient cells. In the first study, 22 and 27 cellular peptides
bound to the murine H-2Kd class I molecule were immunopre-
cipitated from human and mouse TAP-deficient cells respectively
[8]. Later, 50 HLA-A2 or -B51 ligands were presented TAP-
independently in a human TAP-deficient cell line [9]. Currently,
using a sequential immunoprecipitation of several HLA class I
molecules, we identified several hundred TAP-independent
ligands that were processed and presented by the four class I
molecules expressed in the same cell population. Thus, the HLA
peptidome generated by TAP-independent antigen processing
pathways is more diverse than previously assumed. In agreement
Figure 1. Naturally processed peptides from myosin heavy polypeptide 9 identified by mass spectrometry. Diagram of identified
ligands bound to HLA class I molecules in the first 80 (panel A) or last 40 (panel B) residues from myosin heavy chain 9 protein. Ligands specific for
HLA-A2 (white boxes), -B27 (black boxes), and –B51 or –Cw1 (gray boxes) are depicted in the lower section of each panel.
doi:10.1371/journal.pone.0059118.g001
Table 3. HLA restriction and number of proteins from TAP-independent ligands.
Number of HLA alleles % of Proteinsa % of TAP-independent ligandsa
One 75 45
Two 19 22
HLA-A2 and –B27 2 2
HLA-A2 and –B51 or –Cw1 11 10
HLA-B27 and –B51 or –Cw1 6 10
Three 6b 33
aof the total shown in Tables S1, S2, and S3.
bsee Table S5.
doi:10.1371/journal.pone.0059118.t003
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with previous studies [8,9], the major features of the peptide
repertoire bound to classical MHC class I from TAP-deficient cells
revealed increased peptide lengths and a lack of strict binding
motifs in all HLA class I molecules studied in the current report.
The cytosol is a very degradative compartment, having multiple
endoproteases and exopeptidases [1]. In contrast, both the
vesicular compartments and the secretory pathway (source of
TAP-independent ligands) are clearly less degradative [38]. Thus,
the absence of high affinity ligands, generated by the TAP-
dependent antigen processing, allows the interaction between the
high amounts of empty HLA class I molecules and the long TAP-
independent ligands with low affinity from TAP-deficient cells
[8,39]. In addition, in a previous study using the same HLA
peptidome, several vaccinia low affinity ligands were identified
that did not conform to the normal anchor motifs used by HLA-
A2, -B27 and –Cw1 class I molecules [17]. Nonetheless, the
identified HLA-A2 low-affinity ligand generated long-term CTL
memory responses against vaccinia virus, even in an HLA-A2
transgenic TAP+ mouse model [17]. These data and other studies
[40,41] indicate that low-affinity ligands, such as the self-derived
peptides identified in the current report, have functional relevance.
Immunoproteomics analysis of the MHC class II peptidome
usually shows ligands represented by several length variants of the
same core, thereby forming sets of nested peptides varying by
several residues at the N- or C-terminal ends (summarized in
SYFPEITHI database). Further, in the analysis of the TAP-
independent peptide repertoire that is associated with non-classical
MHC class I molecules, HLA-E- [39] and H-2Qa-1b-bound
peptides [42] were identified as length variants of the same central
core. In the current report, multiple sets of up to ten nested
peptides were endogenously presented by different HLA class I
molecules (Table S4), suggesting that amino acid trimming at both
the N- and C- terminus might be a general attribute of TAP-
independent peptides. The similarities between the classical and
non-classical peptide repertoires of HLA class II and TAP-
independent HLA class I suggest at least a partial contribution of
TAP-independent peptide loading in the post invariant chain-
degrading compartments as indicated the existence of unchar-
acterized TAP-independent peptide-HLA-B27 complexes gener-
ated by a chloroquine-sensitive pathway [43].
Unlike previous studies [8,9], the higher number of ligands
identified in the current report allows the identification of
extensive TAP-independent antigen processing mechanisms,
yielding multiple HLA ligands in a reduced subgroup representing
a small number of cellular proteins. Previously, autophagic
processes present at low levels in different cell lines have been
suggested to explain TAP-independent antigen processing [44]. In
addition, as peptides derived from cytosolic proteins are found
bound to class II MHC molecules [45–47], the mechanisms
involved in peptides and/or protein transport from the cytosol to
secretory pathways could be similar for both TAP-independent
class I and class II MHC ligands. This possibility is supported by
our identification of nested sets of TAP-independent peptides that
are very similar to those previously reported to be associated with
HLA class II molecules. The similar composition of the secretory
vesicle proteome that includes both HLA class I and class II
molecules [32], as well as the nested set TAP-independent ligands
identified in the current report, suggest that the antigen processing
of proteins from these or similar organelles could be a relevant
source of the TAP-independent peptidome. This vision of MHC






Cytoplasm 22c 16 23
Cytoskeleton 9 0 8
Endoplasmic reticulum 8 2 4
Extracellular 0 0 5
Golgi 4 1 2
Mitochondria 5 2 6
Nucleus 32 5 22
Plasma membrane 14 2 24
Secretory granuled 6 72 8
afrom human T cells [30,31].
bfrom human neutrophils [32].
cdata are expressed in percentage of proteins listed by cell location based on
gene ontology analysis (http://www.geneontology.org) [29].
dSecretory granule are represented by melanosomes, lysosomes, platelet
granules, endosomes, synaptosomes, exosomes or cytolytic granules as defined
in references [30,31].
doi:10.1371/journal.pone.0059118.t004
Figure 2. Analysis of N- and C-end cleavage specificity in HLA
class I ligands. A diagram of residues involved in the generation of
naturally processed HLA class I ligands by peptidase cleavages is shown
(panel A). Distribution of P1 (panel B) and P91 (panel C) amino acid
residues of the scissile bonds created by peptidase cleavage.
doi:10.1371/journal.pone.0059118.g002
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class I molecules, from cell surface protein recycling, to entering
into classical MHC class II compartments and later being
transported back to the plasma membrane associated with
endocytic/secretory vesicle peptides, might be the case for the
peptides identified in the current report and is supported by two
previous studies. At first, a measles virus F protein epitope was
previously presented by class I molecules in TAP-independent,
acidic-sensitive manner [48]. Second, uncharacterized TAP-in-
dependent peptide-HLA-B27 complexes were generated by
a proteasome-independent, but chloroquine-sensitive, pathway
[43]. Thus, this endocytic/secretory pathway may exist under
normal conditions where it may contribute to a minor fraction of
presented ligands. However, when the highly predominant TAP-
dependent ligands are absent, as in TAP-deficient cells, this
process may predominate.
Individual HLA class I alleles have shown different TAP
dependencies. The prevalent HLA-A2 allele is considered to be
the least TAP-dependent [49]. In contrast, other MHC class I
molecules, including HLA-A3, -A24, and -B27, have been
described as mainly TAP-dependent [26]. In the present report,
a similarly broad TAP-independent peptidome was identified by
MS for these HLA alleles with differing TAP requirements. Thus,
quantitative rather than qualitative differences (probably associat-
ed with the high efficiency rate of the SPase, accounting for the
majority of signal sequence cleavages [50]), are responsible for the
diverse overall expression of various MHC class I molecules in
TAP-deficient cells [43].
The global picture emerging from the current report is
consistent with the model depicted in Figure 4. Some ligands,
mostly HLA-A2-restricted, were processed by the SPase, in
accordance with previous studies [9,43,51,52]. Endoproteolytic
peptidases, exhibiting specificity for Arg/Lys or Phe/Leu in the P1
position of the scissile bond, play an important role in the
generation of many ligands associated with the four HLA class I
alleles studied herein. However, some TAP-independent ligands
must be produced by other, yet uncharacterized protease activities.
Finally, a fraction of the longest variants from the same core
protein could be folded within the HLA molecules, thereby
protecting them from the trimming activity. The remaining
molecules might be accessed by amino and/or carboxypeptidases
Figure 3. Analysis of the correspondence of P1 N- and C-end cleavage specificity in HLA class I ligands. Panel A: A diagram of the
residues involved in the generation of naturally processed HLA class I ligands by peptidase cleavage is shown. P1 residue is indicated by white boxes
(N-end) or black boxes (C-end). Panels B-E: A specific amino acid residue is indicated at the top right corner of each panel and the corresponding
opposite residue identified in P1 N-end (white boxes) or C-end (black boxes) is represented. For example, panel B indicates in white bars the residue
located in the P1 N-end position when Arg was identified in P1 C-end, and in black bars the residue located in the P1 C-end position when Arg was
identified in the P1 N-end position.
doi:10.1371/journal.pone.0059118.g003
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and trimmed to shorter peptides. Several rounds of trimming and
HLA/peptide stabilization of fractions of these peptides could
form the sets of nested peptides identified by mass spectrometry.
Recurrent and sequential amino-terminal trimming and MHC
protection have been demonstrated for a nested set of abundant
and equally antigenic murine HLA class I epitopes from TAP-
sufficient cells that ranged between 9–15 residues [53,54].
Whereas the role of the ER-resident peptidase ERAP in the N-
terminal end trimming of different MHC class I ligands was
previously well defined [55–57], to date, very few studies have
implied a role for carboxypeptidases in antigen processing in the
vesicular pathway. Indirect evidence has been reported in two
cases. First, the proteolytic action of furin in the secretory pathway
is required to generate an antigenic viral epitope [58]. After
cleavage by furin, several C-terminal residues must be trimmed
from the precursor peptide to generate the optimal epitope,
suggesting that carboxypeptidases are involved. Second, several
signal sequence-derived peptides generated by SPase complexes
have C-terminal-extended residues when compared to the optimal
HLA-bound epitope [8,9,42], indicating that carboxypeptidases
may be involved in antigen processing of these ligands. A direct
role for the carboxypeptidase ACE was described for the
processing of peptides for MHC class I [59]. Recently, undefined
carboxypeptidases were involved in the antigen processing of
a vaccinia-derived TAP-independent epitope [60]. Finally, the
present report indirectly implicates carboxyproteases in the
generation of nested sets of peptides bound to several HLA class
I alleles.
In summary, different and complex processing pathways are
required to generate the HLA class I peptide repertoire in TAP-
deficient cells.
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